Bridgepoint Group (LON:BPT) Earns Overweight Rating from JPMorgan Chase & Co.

Bridgepoint Group (LON:BPT)‘s stock had its “overweight” rating reiterated by research analysts at JPMorgan Chase & Co. in a research report issued on Friday,London Stock Exchange reports.

Separately, Citigroup raised shares of Bridgepoint Group to a “buy” rating and set a GBX 410 ($5.59) price objective for the company in a research report on Thursday, March 20th.

Bridgepoint Group Trading Up 0.7%

BPT opened at GBX 323.80 ($4.42) on Friday. Bridgepoint Group has a twelve month low of GBX 229.20 ($3.13) and a twelve month high of GBX 410 ($5.59). The company has a 50-day simple moving average of GBX 289.19 and a 200 day simple moving average of GBX 318.98. The company has a quick ratio of 3.60, a current ratio of 4.98 and a debt-to-equity ratio of 12.89. The stock has a market capitalization of £2.67 billion, a price-to-earnings ratio of 58.82, a P/E/G ratio of 0.61 and a beta of 1.72.

Bridgepoint Group Company Profile

Bridgepoint Group plc is a private equity and private credit firm specializing in middle market, small mid cap, small cap, growth capital, buyouts investments, syndicate debt, infrastructure, direct lending and credit opportunities in private credit investments. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.